Microbiome changes in humans with Parkinson's disease after photobiomodulation therapy : a retrospective study

Brian Bicknell; Ann Liebert; Craig S. McLachlan; Hosen Kiat

doi:10.3390/jpm12010049

Microbiome changes in humans with Parkinson's disease after photobiomodulation therapy : a retrospective study

Brian Bicknell, Ann Liebert, Craig S. McLachlan, Hosen Kiat

Western Sydney University

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

There is a paucity of information on the effect of photobiomodulation therapy on gut micro-biome composition. Parkinson's disease is a progressive neurological disorder with few management options, although the gut microbiome has been suggested as a potential avenue of treatment. We retrospectively analysed the microbiome from human stool samples from a previously published study, which had demonstrated the efficacy of photobiomodulation to treat Parkinson's patients' symptoms. Specifically, we have observed changes in the microbiome of Parkinson's patients after a 12-week treatment regimen with photobiomodulation to the abdomen, neck, head and nose. Noted were positive changes in the Firmicutes to Bacteroidetes (F:B) ratio, which is often interpreted as a proxy for gut health.

Original language	English
Article number	49
Number of pages	15
Journal	Journal of Personalized Medicine
Volume	12
Issue number	1
DOIs	https://doi.org/10.3390/jpm12010049
Publication status	Published - Jan 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Open Access - Access Right Statement

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Access to Document

10.3390/jpm12010049

Cite this

@article{e05de7ac8d854ae3bc42d804c750d8a0,

title = "Microbiome changes in humans with Parkinson's disease after photobiomodulation therapy : a retrospective study",

abstract = "There is a paucity of information on the effect of photobiomodulation therapy on gut micro-biome composition. Parkinson's disease is a progressive neurological disorder with few management options, although the gut microbiome has been suggested as a potential avenue of treatment. We retrospectively analysed the microbiome from human stool samples from a previously published study, which had demonstrated the efficacy of photobiomodulation to treat Parkinson's patients' symptoms. Specifically, we have observed changes in the microbiome of Parkinson's patients after a 12-week treatment regimen with photobiomodulation to the abdomen, neck, head and nose. Noted were positive changes in the Firmicutes to Bacteroidetes (F:B) ratio, which is often interpreted as a proxy for gut health.",

author = "Brian Bicknell and Ann Liebert and McLachlan, {Craig S.} and Hosen Kiat",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = jan,

doi = "10.3390/jpm12010049",

language = "English",

volume = "12",

journal = "Journal of Personalized Medicine",

issn = "2075-4426",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "1",

}

TY - JOUR

T1 - Microbiome changes in humans with Parkinson's disease after photobiomodulation therapy : a retrospective study

AU - Bicknell, Brian

AU - Liebert, Ann

AU - McLachlan, Craig S.

AU - Kiat, Hosen

PY - 2022/1

Y1 - 2022/1

N2 - There is a paucity of information on the effect of photobiomodulation therapy on gut micro-biome composition. Parkinson's disease is a progressive neurological disorder with few management options, although the gut microbiome has been suggested as a potential avenue of treatment. We retrospectively analysed the microbiome from human stool samples from a previously published study, which had demonstrated the efficacy of photobiomodulation to treat Parkinson's patients' symptoms. Specifically, we have observed changes in the microbiome of Parkinson's patients after a 12-week treatment regimen with photobiomodulation to the abdomen, neck, head and nose. Noted were positive changes in the Firmicutes to Bacteroidetes (F:B) ratio, which is often interpreted as a proxy for gut health.

AB - There is a paucity of information on the effect of photobiomodulation therapy on gut micro-biome composition. Parkinson's disease is a progressive neurological disorder with few management options, although the gut microbiome has been suggested as a potential avenue of treatment. We retrospectively analysed the microbiome from human stool samples from a previously published study, which had demonstrated the efficacy of photobiomodulation to treat Parkinson's patients' symptoms. Specifically, we have observed changes in the microbiome of Parkinson's patients after a 12-week treatment regimen with photobiomodulation to the abdomen, neck, head and nose. Noted were positive changes in the Firmicutes to Bacteroidetes (F:B) ratio, which is often interpreted as a proxy for gut health.

UR - https://hdl.handle.net/1959.7/uws:76052

U2 - 10.3390/jpm12010049

DO - 10.3390/jpm12010049

M3 - Article

SN - 2075-4426

VL - 12

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

IS - 1

M1 - 49

ER -

Microbiome changes in humans with Parkinson's disease after photobiomodulation therapy : a retrospective study

Abstract

Bibliographical note

Open Access - Access Right Statement

Access to Document

Other files and links

Fingerprint

Cite this